Grant: Catalyst Grant: STBBI Research in Canada: Beyond HIV/AIDS/Hepatitis C - General
University of British Columbia
$99,990.00
Characterizing the disease burden from hepatitis B virus in British Columbia, Canada
FY 2021-22
Summary
Hepatitis B virus (HBV) is a significant source of morbidity and mortality in Canada and globally. In 2015, HBV-related complications accounted for 66% of viral hepatitis-related deaths worldwide. Large proportions of people living with chronic HBV may be unaware of their infections due to the asymptomatic nature of the early phases of the disease, and may get diagnosed once they develop symptoms during advanced stages of the illness. Thus, screening is essential for early diagnosis of HBV infection, and for timely linkage with care and treatment initiation to slow disease progression. Groups facing the greatest burden of disease from HBV in Canada include persons immigrating from HBV-endemic countries in East Asia, Southeast Asia, and Sub-Saharan Africa, where HBV is highly prevalent (HBsAg: ~6.2%-10.5%), unimmunized people who inject drugs, gay, bisexual, and other men who have sex with men, and Indigenous Peoples. Immigrants in Canada may be diagnosed and linked with care late in the course of their infections and, consequently, have an increased risk of hospitalization for complications related to HBV. Canada has committed to reducing HBV incidence and HBV-related mortality by 95% and 65%, respectively, by 2030 but is lacking national and provincial action plans for HBV elimination. These action plans would require measurable indicators of hepatitis-related services for progress tracking and program evaluation. Comprehensive population-level HBV data are necessary for the creation of care cascades and other tools for program planning and evaluation but are currently unavailable for HBV in British Columbia. This project aims to provide a detailed understanding of the epidemiology of HBV in British Columbia by developing a comprehensive, dynamic, population-level integrated dataset comprised of linked laboratory and administrative data to support the mapping of a current HBV care cascade and to highlight areas for improvement in the continuum of care in BC.
Department
Program
Catalyst Grant: STBBI Research in Canada: Beyond HIV/AIDS/Hepatitis C - General
Recipient
Location
British Columbia, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
453437
Name
Janjua Naveed Z
Region
British Columbia
Country
Canada
Orgtype
Research Institution; Institution Paid
Instname2
Infection and Immunity
Theme2
Social / Cultural / Environmental / Population Health
Prcname2
Catalyst Grant - STBBI Research in Canada: Beyond HIV/AIDS and Hepatitis C
Projecttitle
Characterizing the disease burden from hepatitis B virus in British Columbia, Canada
Programtype2
Operating Grants
Orgnameinp2
University of British Columbia
Cihramount2
$99,990
Cihrequipment2
$0
Programname2
Catalyst Grant: STBBI Research in Canada: Beyond HIV/AIDS/Hepatitis C - General
Keyworddelim
Care Cascade; Disease Burden; Hepatitis B; Integrated Data; Syndemics
Abstract
Hepatitis B virus (HBV) is a significant source of morbidity and mortality in Canada and globally. In 2015, HBV-related complications accounted for 66% of viral hepatitis-related deaths worldwide. Large proportions of people living with chronic HBV may be unaware of their infections due to the asymptomatic nature of the early phases of the disease, and may get diagnosed once they develop symptoms during advanced stages of the illness. Thus, screening is essential for early diagnosis of HBV infection, and for timely linkage with care and treatment initiation to slow disease progression. Groups facing the greatest burden of disease from HBV in Canada include persons immigrating from HBV-endemic countries in East Asia, Southeast Asia, and Sub-Saharan Africa, where HBV is highly prevalent (HBsAg: ~6.2%-10.5%), unimmunized people who inject drugs, gay, bisexual, and other men who have sex with men, and Indigenous Peoples. Immigrants in Canada may be diagnosed and linked with care late in the course of their infections and, consequently, have an increased risk of hospitalization for complications related to HBV. Canada has committed to reducing HBV incidence and HBV-related mortality by 95% and 65%, respectively, by 2030 but is lacking national and provincial action plans for HBV elimination. These action plans would require measurable indicators of hepatitis-related services for progress tracking and program evaluation. Comprehensive population-level HBV data are necessary for the creation of care cascades and other tools for program planning and evaluation but are currently unavailable for HBV in British Columbia. This project aims to provide a detailed understanding of the epidemiology of HBV in British Columbia by developing a comprehensive, dynamic, population-level integrated dataset comprised of linked laboratory and administrative data to support the mapping of a current HBV care cascade and to highlight areas for improvement in the continuum of care in BC.
Competitiondate
202106
Approvedterm2
1 yr 0 mth
Pinamesdelim
Janjua, Naveed Z; Binka, Mawuena
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $99,990~ $0~